Skip to main content
Top
Published in: Pathology & Oncology Research 2/2011

01-06-2011 | Communication

Breast Cancer under 40 Years of Age: Increasing Number and Worse Prognosis

Authors: Ágnes Dobi, Gyöngyi Kelemen, László Kaizer, Roland Weiczner, László Thurzó, Zsuzsanna Kahán

Published in: Pathology & Oncology Research | Issue 2/2011

Login to get access

Abstract

Breast cancer at a relatively young age with a poor prognosis is currently exhibiting an increasing incidence. In a retrospective cohort analysis of early breast cancer cases after surgery from our institutional patient registry, 141 patients aged ≤40 years constituted the younger group, with 300 randomly selected patients aged >40 years as controls. A significant and steady increase was found in the relative number of younger cases during the years 2004–2009. The histological type and grade and the lymph node status of the cancers differed significantly between the two groups, with more aggressive biological behaviour, a more advanced stage and a worse prognosis in the younger group. Half of the cancers in the younger cohort were ER-negative, while two-thirds in the control group were ER-positive. Comparatively more tumours were PR-positive and HER2-negative in the control group than in the younger group. The rates of triple-negative cases were 25% and 13% in the younger age and the control group, respectively (p = 0.026). Significantly higher mastectomy and axillary block dissection rates were observed in the younger age group, and more chemotherapy was administered than in the control group. Our findings demonstrate the significance of breast cancer in cases aged <40 years, and draw attention to the need for appropriate care in these cases.
Literature
1.
go back to reference Agarwal G, Pradeep PV, Aggarwal V et al (2007) Spectrum of breast cancer in Asian women. World J Surg 31:1031–1040PubMedCrossRef Agarwal G, Pradeep PV, Aggarwal V et al (2007) Spectrum of breast cancer in Asian women. World J Surg 31:1031–1040PubMedCrossRef
2.
go back to reference Brinton LA, Sherman ME, Carreon JD, Anderson WF (2008) Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst 100:1643–1648PubMedCrossRef Brinton LA, Sherman ME, Carreon JD, Anderson WF (2008) Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst 100:1643–1648PubMedCrossRef
3.
go back to reference Bouchardy C, Fioretta G, Verkooijen HM et al (2007) Recent increase of breast cancer incidence among women under the age of forty. Br J Cancer 96:1743–1746PubMedCrossRef Bouchardy C, Fioretta G, Verkooijen HM et al (2007) Recent increase of breast cancer incidence among women under the age of forty. Br J Cancer 96:1743–1746PubMedCrossRef
4.
go back to reference Fredholm H, Eaker S, Frisell J et al (2009) Breast cancer in young women: poor survival despite intensive treatment. PLoS One 4:e7695PubMedCrossRef Fredholm H, Eaker S, Frisell J et al (2009) Breast cancer in young women: poor survival despite intensive treatment. PLoS One 4:e7695PubMedCrossRef
5.
go back to reference Chung M, Chang HR, Bland KI, Wanebo HJ (1996) Younger women with breast carcinoma have a poorer prognosis than older women. Cancer 77:97–103PubMedCrossRef Chung M, Chang HR, Bland KI, Wanebo HJ (1996) Younger women with breast carcinoma have a poorer prognosis than older women. Cancer 77:97–103PubMedCrossRef
8.
go back to reference Maggard MA, O’Connell JB, Lane KE et al (2003) Do young breast cancer patients have worse outcomes? J Surg Res 113:109–113PubMedCrossRef Maggard MA, O’Connell JB, Lane KE et al (2003) Do young breast cancer patients have worse outcomes? J Surg Res 113:109–113PubMedCrossRef
9.
go back to reference Fernandopulle SM, Cher-Siangang P, Tan PH (2006) Breast carcinoma in women 35 years and younger: a pathological study. Pathology 38:219–222PubMedCrossRef Fernandopulle SM, Cher-Siangang P, Tan PH (2006) Breast carcinoma in women 35 years and younger: a pathological study. Pathology 38:219–222PubMedCrossRef
10.
go back to reference Colleoni M, Rotmensz N, Robertson C et al (2002) Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol 13:273–279PubMedCrossRef Colleoni M, Rotmensz N, Robertson C et al (2002) Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol 13:273–279PubMedCrossRef
11.
go back to reference Anders CK, Hsu DS, Breakwater G et al (2008) Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26:3324–3330PubMedCrossRef Anders CK, Hsu DS, Breakwater G et al (2008) Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26:3324–3330PubMedCrossRef
12.
go back to reference Bori R, Cserni G (2009) Basal phenotype in breast carcinoma occurring in women aged 35 or younger. Pathol Oncol Res 15:41–45PubMedCrossRef Bori R, Cserni G (2009) Basal phenotype in breast carcinoma occurring in women aged 35 or younger. Pathol Oncol Res 15:41–45PubMedCrossRef
13.
go back to reference Cabanes A, Vidal E, Pérez-Gómez B et al (2009) Age-specific breast, uterine and ovarian cancer mortality trends in Spain: Changes from 1980–2006. Cancer Epid 33:169–175CrossRef Cabanes A, Vidal E, Pérez-Gómez B et al (2009) Age-specific breast, uterine and ovarian cancer mortality trends in Spain: Changes from 1980–2006. Cancer Epid 33:169–175CrossRef
14.
go back to reference Székely B, Madaras L, Gy S et al (2010) A fiatal és időskori emlőrák összehasonlítása klinikopathológiai jellemzők alapján. Magy Onkol 54:19–26PubMedCrossRef Székely B, Madaras L, Gy S et al (2010) A fiatal és időskori emlőrák összehasonlítása klinikopathológiai jellemzők alapján. Magy Onkol 54:19–26PubMedCrossRef
Metadata
Title
Breast Cancer under 40 Years of Age: Increasing Number and Worse Prognosis
Authors
Ágnes Dobi
Gyöngyi Kelemen
László Kaizer
Roland Weiczner
László Thurzó
Zsuzsanna Kahán
Publication date
01-06-2011
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 2/2011
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-010-9305-3

Other articles of this Issue 2/2011

Pathology & Oncology Research 2/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine